Patent US5496698A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5496698A Expired / Lapsed US ⏱️ 0.0 years remaining

Method of isolating ribozyme targets

Assignee: Sirna Therapeutics Inc
•
Filing: 1992-12-07
•
Granted: 1996-03-05
•
Expires: 2012-12-07
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Method for in vivo selection of a ribozyme active at a defined RNA target.

Inventors

  • 👤 Kenneth G. Draper
  • 👤 Dennis G. Macejak

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-07 14:06
CPC Classifications
C; C12; C12N; C12N15/00; C12N15/09; C12N15/11; C12N15/113; C07; C07K; C07K14/00; C07K14/005; C12N15/63; C12N15/79; C12N15/85; C12N15/86; A; A61; A61K; A61K38/00; C12N2310/00; C12N2310/10; C12N2310/12; C12N2310/121; C12N2310/122; C12N2310/30; C12N2310/31; C12N2310/315; C12N2310/32; C12N2310/321; C12N2310/322; C12N2310/35; C12N2310/352; C12N2310/3521; C12N2310/353; C12N2310/3531; C12N2310/3533; C12N2310/3535; C12N2710/00; C12N2710/00011; C12N2710/16011; C12N2710/16611; C12N2710/16622

Claims Analysis

Total Claims: 19
Claim 1
Independent Claim 151 words
A method for in vivo selection of a ribozyme active on a defined RNA target, comprising the steps of: introducing a first population of ribozymes, in which each said ribozyme has a different substrate binding arm, into a second population of cultured cells, wherein said ribozymes are formed from a third population of fragmented target DNA molecules encoding said RNA target into each of which an enzymatic portion of a ribozyme is inserted; providing said RNA target to said second population of cultured cells, and identifying those cells which contain a ribozyme active at the RNA target; wherein said third population is formed by fragmenting target DNA encoding said defined RNA target with DNAseI, and introducing an enzymatic portion of a ribozyme encoding sequence within the fragments generated by said fragmenting by cleaving each said fragment and then ligating said enzymatic portion of a ribozyme encoding sequence into each said fragment.
Claim 2
Independent Claim 151 words
A method for in vivo selection of a ribozyme active on a defined RNA target, comprising the steps of: introducing a first population of ribozymes, in which each said ribozyme has a different substrate binding arm, into a second population of cultured cells, wherein said ribozymes are formed from a third population of fragmented target DNA molecules encoding said RNA target into each of which an enzymatic portion of a ribozyme is inserted; providing said RNA target to said second population of cultured cells, and identifying those cells which contain a ribozyme active at the RNA target; wherein said third population is formed by fragmenting target DNA encoding said defined RNA target with DNAseI, and introducing an enzymatic portion of a ribozyme encoding sequence within the fragments generated by said fragmenting by cleaving each said fragment and then ligating said enzymatic portion of a ribozyme encoding sequence into each said fragment.
Claim 3
Dependent Claim 19 words
The method of claim 1, wherein said cleaving of each said fragment is by use of a restriction endonuclease.
Claim 4
Dependent Claim 17 words
The method of claim 2, wherein said restriction endonuclease recognizes a site outside of said target sequence.
Claim 5
Dependent Claim 19 words
The method of claim 2, wherein said restriction endonuclease is selected from the group consisting of BpmI and BsgI.
Claim 6
Dependent Claim 30 words
The method of claim 1, wherein said ribozymes are encoded by an expression vector, and said method comprises causing said ribozymes to be expressed from said vector in said cells.
Claim 7
Dependent Claim 29 words
The method of claim 1, wherein said RNA target is a viral RNA and said identifying includes determining cell survival after infection of said cells by said viral RNA.
Claim 8
Dependent Claim 19 words
The method of claim 1, wherein said RNA target is a mammalian RNA and said cells are mammalian cells.
Claim 9
Dependent Claim 23 words
The method of claim 5, wherein said vector comprises sequences encoding a 5' or 3' hairpin or a poly(A) tail for said ribozyme.
Claim 10
Dependent Claim 25 words
The method of claim 5, wherein said ribozyme is a hammerhead ribozyme having at least one substrate binding arm comprising between six and eight nucleotides.
Claim 11
Dependent Claim 23 words
The method of claim 1, wherein said identifying comprises detecting expression of a reporter RNA attached to or regulated by said RNA target.
Claim 12
Dependent Claim 20 words
The method of claim 1, wherein said ribozyme active at the RNA target is recloned into an amphitrophic retrovirus vector.
Claim 13
Dependent Claim 25 words
The method of claim 11, wherein a said retrovirus vector having or encoding said ribozyme is selected for ribozyme activity active at said RNA target.
Claim 14
Dependent Claim 58 words
The method of claim 1, wherein said first population of ribozymes have the formula 5' NCNA 3' wherein each N is or encodes a ribozyme substrate binding arm, C is or encodes an enzymatic portion of a ribozyme, and A is a polyadenylation sequence; wherein at least one said N in said population differs in each said ribozyme.
Claim 15
Dependent Claim 20 words
The method of claim 13, wherein said formula is 5' RNCNAS 3' wherein R and S are restriction endonuclease sites.
Claim 16
Dependent Claim 51 words
The method of claim 13, wherein said formula is 5' RLNCNLALS 3' wherein each said L independently is nothing or an insertion region which is or encodes a nuclear processing signal, an RNA stability signal, a splicing signal, or another nucleotide signal which effects transport or stability of said ribozyme molecule.
Claim 17
Dependent Claim 35 words
The method of claim 15, wherein said formula is 5' RLCNLALSH 3' where H is a sequence which is or encodes a hairpin ribozyme or a hepatitis delta ribozyme which cleaves 3' of said S.
Claim 18
Dependent Claim 46 words
The method of claim 16, wherein said formula is 5' DRLCNLALSE 3' wherein D and E are defined nucleotide sequences which can be used to prime amplification of a said molecule, or the complement of which can be used to prime amplification of a said molecule.
Claim 19
Dependent Claim 23 words
The method of claim 17, wherein each N is formed by fragmenting a target DNA and inserting said C within each said fragment.

References Cited (Backward Citations)

WO1991015580A1 Cited
WO1991018913A1 Cited
WO1991018625A1 Cited
WO1991018624A1 Cited
WO1992000080A1 Cited
WO1992001806A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1999-03-05 1999-09-04 2000-03-05 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2003-03-05 2003-09-04 2004-03-05 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2007-03-05 2007-09-04 2008-03-05 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag